1. Case Reports and Drug Safety

   • EP van Puijenbroek

   Editorial 09 January 2013 Pages: 643 - 645

2. Long-Acting β₂-Agonists in Asthma

   • Graeme P. Currie
   • Daniel K.C. Lee
   • Brian J. Lipworth

   Current Opinion 09 January 2013 Pages: 647 - 656

   

3. Pharmacovigilance during the Pre-Approval Phases

   • Craig G. Hartford
   • Kasia S. Petchel
   • Paula Marquez

   Leading Article 09 January 2013 Pages: 657 - 673

   

4. Safety of Etanercept in Psoriasis

   • Jose L. Sánchez Carazo
   • Laura Mahiques Santos
   • Vicente Oliver Martinez

   Review Article 09 January 2013 Pages: 675 - 685

   

5. Serious Skin Reactions and Selective COX-2 Inhibitors

   • Deborah Layton
   • Vanessa Marshall
   • Saad AW Shakir

   Short Communication 09 January 2013 Pages: 687 - 696

   

6. Can Decisional Algorithms Replace Global Introspection in the Individual Causality Assessment of Spontaneously Reported ADRs?

   • Ana F. Macedo
   • Francisco B. Marques
   • Carlos F. Ribeiro

   Original Research Article 09 January 2013 Pages: 697 - 702

   

7. Effect of Ezetimibe and/or Simvastatin on Coenzyme Q10 Levels in Plasma

   • Heiner K. Berthold
   • Ali Naini
   • Ioanna Gouni-Berthold

   Original Research Article 09 January 2013 Pages: 703 - 712

   

8. Drug-Induced Thrombocytopenia

   • Maarten J. ten Berg
   • Albert Huisman
   • Patricia M.L.A. van den Bemt

   Original Research Article 09 January 2013 Pages: 713 - 721

   

9. Clinical Risk Management in Dutch Community Pharmacies

   • Henk Buurma
   • Peter A.G.M De Smet
   • Antoine C.G. Egberts

   Original Research Article 09 January 2013 Pages: 723 - 732

   

10. An Industry Perspective on the Erice Declaration and Risk Minimisation Plans

    • Simon Ingate
    • Deborah Tranter
    • Andrew Hobbs

    Correspondence 09 January 2013 Pages: 733 - 734